| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/TID.12465 |
| P698 | PubMed publication ID | 26437369 |
| P2093 | author name string | D Thomas | |
| M Toyoda | |||
| S Ge | |||
| S C Jordan | |||
| M Chu | |||
| A Vo | |||
| J Kahwaji | |||
| E Suviolahti | |||
| J Mirocha | |||
| G Ahn | |||
| P2860 | cites work | Monoclonal antibodies and progressive multifocal leukoencephalopathy | Q28270413 |
| PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
| Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project | Q33383576 | ||
| Progressive multifocal leukoencephalopathy in HIV-1 infection | Q33506561 | ||
| Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. | Q34052870 | ||
| Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier | Q34085827 | ||
| Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients | Q34263748 | ||
| Risk of natalizumab-associated progressive multifocal leukoencephalopathy | Q34275329 | ||
| Polyomavirus BK neutralizing activity in human immunoglobulin preparations | Q34786755 | ||
| JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals | Q35194420 | ||
| Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin | Q35664634 | ||
| Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis | Q36190565 | ||
| A review on JC virus infection in kidney transplant recipients. | Q36602840 | ||
| Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies | Q37980042 | ||
| HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity. | Q41509979 | ||
| Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome | Q41906877 | ||
| Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab | Q42274057 | ||
| Recovery of functional memory T cells in lung transplant recipients following induction therapy with alemtuzumab | Q43432898 | ||
| JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients | Q44925922 | ||
| JC virus DNA in the peripheral blood of renal transplant patients: a 1-year prospective follow-up in France. | Q45134354 | ||
| Anti-JC virus antibodies: implications for PML risk stratification | Q45373492 | ||
| Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients | Q45387450 | ||
| Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation | Q45396476 | ||
| A comparative study of BK and JC virus infections in organ transplant recipients | Q45424471 | ||
| Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. | Q45953243 | ||
| Rituximab and intravenous immune globulin for desensitization during renal transplantation | Q46477840 | ||
| Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis | Q48420901 | ||
| Immunologic parameters and viral infections in patients desensitized with intravenous immunoglobulin and rituximab. | Q51028676 | ||
| Polyomaviruses BK- And JC-DNA quantitation in kidney allograft biopsies. | Q54514337 | ||
| Progressive multifocal leukoencephalopathy in transplant recipients | Q56060082 | ||
| P433 | issue | 6 | |
| P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
| Human polyomavirus 2 | Q1676563 | ||
| P304 | page(s) | 838-847 | |
| P577 | publication date | 2015-10-05 | |
| P1433 | published in | Transplant Infectious Disease | Q15749562 |
| P1476 | title | JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab | |
| P478 | volume | 17 |
| Q47563660 | Desensitisation strategies in high-risk children before kidney transplantation. |
| Q30397952 | Desensitization: Overcoming the Immunologic Barriers to Transplantation |
| Q37652611 | Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients. |
| Q48655730 | Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipients |
| Q40586736 | Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients |
Search more.